The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
| Autor: | Rob Lavigne, Martin Zizi, Andrzej Górski, Nina Chanishvili, Joana Azeredo, Isabelle Huys, Maia Merabishvili, Guy Van den Mooter, Mario Vaneechoutte, Jean-Paul Pirnay, Angus Buckling, Elisabeth Kutter, Revaz Adamia, Flavie Pouillot, Daniel De Vos, Laurent Debarbieux, Geert Laire, Alain Dublanchet, Gilbert Verbeken |
|---|---|
| Přispěvatelé: | Physiology, Universidade do Minho, Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital [Brussels], George Eliava Institute of Bacteriophages, Microbiology and Virology [Tbilisi, Georgia], Universiteit Gent = Ghent University [Belgium] (UGENT), Brussels Free University, Office of the Surgeon General, Belgian Defence, Université Catholique de Louvain = Catholic University of Louvain (UCL), Department of Zoology, University of Oxford [Oxford], Biologie Moléculaire du Gène chez les Extrêmophiles (BMGE), Institut Pasteur [Paris], Pherecydes Pharma, Evergreen State College, Centre Hospitalier Intercommunal Villeneuve-Saint-Georges (CHIV), Medical University of Warsaw - Poland, Universiteit Gent = Ghent University (UGENT), University of Oxford, Institut Pasteur [Paris] (IP), Universidade do Minho = University of Minho [Braga] |
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
antibiotic resistance
bacteriophages phage therapy Drug Industry Phage therapy MESH: Bacterial Infections medicine.medical_treatment [SDV]Life Sciences [q-bio] viruses Pharmacology toxicology education Pharmaceutical Science Pharmacy Biology drugs Microbiology 03 medical and health sciences MESH: Anti-Bacterial Agents medicine Humans Pharmacology (medical) MESH: Bacteriophages ComputingMilieux_MISCELLANEOUS health care economics and organizations 030304 developmental biology Pharmacology 0303 health sciences MESH: Humans Science & Technology 030306 microbiology business.industry Organic Chemistry bacterial infection Bacterial Infections Virology humanities Anti-Bacterial Agents 3. Good health Bacteriophage Therapy MESH: Drug Industry Molecular Medicine business Biotechnology |
| Zdroj: | Pharmaceutical Research Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2010, 28 (4), pp.934-937. ⟨10.1007/s11095-010-0313-5⟩ Pharmaceutical Research, 2010, 28 (4), pp.934-937. ⟨10.1007/s11095-010-0313-5⟩ |
| ISSN: | 0724-8741 1573-904X |
| Popis: | The present opinion is the result of discussions on the future of phage therapy (personalized or large-scale uniform therapy?) during the first International Congress on Viruses of Microbes, held at the Institut Pasteur in Paris on June 21–25, 2010. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink